Published in Lung Cancer on February 20, 2006
Transformation from non-small-cell lung cancer to small-cell lung cancer: molecular drivers and cells of origin. Lancet Oncol (2015) 2.73
Proteomic profiling identifies dysregulated pathways in small cell lung cancer and novel therapeutic targets including PARP1. Cancer Discov (2012) 2.68
Treatment options for small cell lung cancer - do we have more choice? Br J Cancer (2010) 1.07
Dual inhibition of EGFR and mTOR pathways in small cell lung cancer. Br J Cancer (2010) 1.06
Lung cancer: Biology and treatment options. Biochim Biophys Acta (2015) 1.02
Targeted therapies in small cell lung cancer. Oncol Lett (2012) 0.92
Targeted therapies in small cell lung cancer: a review. Ther Adv Med Oncol (2010) 0.91
Annotation of human cancers with EGFR signaling-associated protein complexes using proximity ligation assays. Sci Signal (2015) 0.90
The development of targeted therapy in small cell lung cancer. J Thorac Dis (2013) 0.90
Neuroendocrine differentiation in acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitor. Tuberc Respir Dis (Seoul) (2013) 0.89
Overcoming chemoresistance of small-cell lung cancer through stepwise HER2-targeted antibody-dependent cell-mediated cytotoxicity and VEGF-targeted antiangiogenesis. Sci Rep (2013) 0.86
Expression and mutation of the c-kit gene and correlation with prognosis of small cell lung cancer. Oncol Lett (2012) 0.84
Small cell lung cancer (SCLC): no treatment advances in recent years. Transl Lung Cancer Res (2016) 0.79
Is the Canonical RAF/MEK/ERK Signaling Pathway a Therapeutic Target in SCLC? J Thorac Oncol (2016) 0.78
Pulmonary Large-Cell Neuroendocrine Carcinoma: From Epidemiology to Therapy. J Thorac Oncol (2015) 0.78
Targeted drugs in small-cell lung cancer. Transl Lung Cancer Res (2016) 0.77
Hyperglycemia Associated With Targeted Oncologic Treatment: Mechanisms and Management. Oncologist (2016) 0.77
Gefitinib efficacy in relapsed small-cell lung cancer. Lung Cancer (2006) 0.77
Angiogenesis inhibitors for the treatment of small cell lung cancer (SCLC): A meta-analysis of 7 randomized controlled trials. Medicine (Baltimore) (2017) 0.75
Immunotherapy treatments for small-cell lung cancer: past, present and future. Lung Cancer Manag (2015) 0.75
Research progress in the treatment of small cell lung cancer. J Cancer (2017) 0.75
Mathematical optimisation of the cisplatin plus etoposide combination for managing extensive-stage small-cell lung cancer patients. Br J Cancer (2017) 0.75
Guideline update for MASCC and ESMO in the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: results of the Perugia consensus conference. Ann Oncol (2010) 5.96
Phase III multicenter randomized trial of the Dartmouth regimen versus dacarbazine in patients with metastatic melanoma. J Clin Oncol (1999) 5.95
Cis-diamminedichloroplatinum, vinblastine, and bleomycin combination chemotherapy in disseminated testicular cancer. Ann Intern Med (1977) 4.91
The natural history of systemic lupus erythematosus by prospective analysis. Medicine (Baltimore) (1971) 4.65
High-level semi-synthetic production of the potent antimalarial artemisinin. Nature (2013) 3.80
Drugs five years later. Cisplatin. Ann Intern Med (1984) 3.69
Treatment of disseminated germ-cell tumors with cisplatin, bleomycin, and either vinblastine or etoposide. N Engl J Med (1987) 3.52
Prevention of islet allograft rejection with engineered myoblasts expressing FasL in mice. Science (1996) 3.35
Clinical evaluation of once-weekly dosing of epoetin alfa in chemotherapy patients: improvements in hemoglobin and quality of life are similar to three-times-weekly dosing. J Clin Oncol (2001) 3.06
Role of ER export signals in controlling surface potassium channel numbers. Science (2001) 2.93
A randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study. J Clin Oncol (1992) 2.90
Phase III trial of gemcitabine plus cisplatin versus cisplatin alone in patients with locally advanced or metastatic non-small-cell lung cancer. J Clin Oncol (2000) 2.73
Thoracic radiotherapy does not prolong survival in patients with locally advanced, unresectable non-small cell lung cancer. Ann Intern Med (1990) 2.64
Immobilization of Notch ligand, Delta-1, is required for induction of notch signaling. J Cell Sci (2000) 2.57
Comparison of the autoSCAN-W/A rapid bacterial identification system and the Vitek AutoMicrobic system for identification of gram-negative bacilli. J Clin Microbiol (1991) 2.51
The status of women at one academic medical center. Breaking through the glass ceiling. JAMA (1990) 2.47
Molecular biology of Hendra and Nipah viruses. Microbes Infect (2001) 2.33
The exceptionally large genome of Hendra virus: support for creation of a new genus within the family Paramyxoviridae. J Virol (2000) 2.26
Evaluation of the novel myocardial perfusion positron-emission tomography tracer 18F-BMS-747158-02: comparison to 13N-ammonia and validation with microspheres in a pig model. Circulation (2009) 2.15
No evidence of acute cardiovascular complications of chemotherapy for testicular cancer: an analysis of the Testicular Cancer Intergroup Study. J Clin Oncol (1992) 2.11
The Notch ligand, Jagged-1, influences the development of primitive hematopoietic precursor cells. Blood (1998) 2.05
Effect of long-term mild hypothermia therapy in patients with severe traumatic brain injury: 1-year follow-up review of 87 cases. J Neurosurg (2000) 2.04
Combination chemotherapy in disseminated testicular cancer: the Indiana University experience. Semin Oncol (1979) 1.91
Late relapse of testicular cancer. J Clin Oncol (1995) 1.87
The development of non-germ cell malignancies within germ cell tumors. A clinicopathologic study of 11 cases. Cancer (1984) 1.85
A phase III randomized study comparing cisplatin and fluorouracil as single agents and in combination for advanced squamous cell carcinoma of the head and neck. J Clin Oncol (1992) 1.84
Chemotherapy of disseminated testicular cancer. A random prospective study. Cancer (1980) 1.79
High-dose chemotherapy as salvage treatment in germ cell tumors: a multivariate analysis of prognostic variables. J Clin Oncol (1996) 1.77
Intrapleural therapy for malignant pleural effusions. A randomized comparison of bleomycin and tetracycline. Chest (1991) 1.72
Vinblastine plus ifosfamide plus cisplatin as initial salvage therapy in recurrent germ cell tumor. J Clin Oncol (1998) 1.72
Long-term follow-up of a phase III intergroup study of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study. J Clin Oncol (1997) 1.70
Decision analysis for avoiding postchemotherapy surgery in patients with disseminated nonseminomatous germ cell tumors. J Clin Oncol (1997) 1.70
Mitochondrial dynamics regulates migration and invasion of breast cancer cells. Oncogene (2012) 1.69
Management of postchemotherapy residual mass in patients with advanced seminoma: Indiana University experience. J Clin Oncol (1989) 1.68
Stabilization of ion selectivity filter by pore loop ion pairs in an inwardly rectifying potassium channel. Proc Natl Acad Sci U S A (1997) 1.67
Novel formulations of taxanes: a review. Old wine in a new bottle? Ann Oncol (2005) 1.65
Altered expression of Ape1/ref-1 in germ cell tumors and overexpression in NT2 cells confers resistance to bleomycin and radiation. Cancer Res (2001) 1.64
Tioman virus, a novel paramyxovirus isolated from fruit bats in Malaysia. Virology (2001) 1.62
Hepatic resection of metastatic testicular carcinoma: a further update. Ann Surg Oncol (1999) 1.59
A genomewide suppressor and enhancer analysis of cdc13-1 reveals varied cellular processes influencing telomere capping in Saccharomyces cerevisiae. Genetics (2008) 1.58
Renal involvement in systemic lupud erythematosus (SLE): a study of 56 patients emphasizing histologic classification. Medicine (Baltimore) (1978) 1.57
Influence of in vitro susceptibility testing conditions on the anti-candidal activity of LY121019. Diagn Microbiol Infect Dis (1988) 1.57
Superiority of nabilone over prochlorperazine as an antiemetic in patients receiving cancer chemotherapy. N Engl J Med (1979) 1.57
Phase I feasibility trial of stereotactic body radiation therapy for primary hepatocellular carcinoma. Clin Transl Oncol (2010) 1.55
Evaluation of a continuous cardiac output and mixed venous oxygen saturation catheter in critically ill surgical patients. Crit Care Med (1997) 1.52
Cisplatin plus doxorubicin plus cyclophosphamide in metastatic or recurrent thymoma: final results of an intergroup trial. The Eastern Cooperative Oncology Group, Southwest Oncology Group, and Southeastern Cancer Study Group. J Clin Oncol (1994) 1.51
Combination chemotherapy with or without thoracic radiotherapy in limited-stage small-cell lung cancer: a randomized trial of the Southeastern Cancer Study Group. J Clin Oncol (1993) 1.51
Cisplatin-based combination chemotherapy for disseminated germ cell tumors: long-term follow-up. J Clin Oncol (1988) 1.49
Calibration of HCV working reagents for NAT assays against the HCV international standard. The Collaborative Study Group. Vox Sang (2000) 1.49
Evidence that the nucleotide exchange and hydrolysis cycle of G proteins causes acute desensitization of G-protein gated inward rectifier K+ channels. Proc Natl Acad Sci U S A (1998) 1.46
Metastatic patterns of choroidal melanoma. Cancer (1974) 1.45
HuD RNA recognition motifs play distinct roles in the formation of a stable complex with AU-rich RNA. Mol Cell Biol (2000) 1.44
Long-term follow-up of patients with lupus nephritis. A study based on the classification of the World Health Organization. Am J Med (1987) 1.42
Molecular recognition of tRNA by tRNA pseudouridine 55 synthase. Biochemistry (1998) 1.42
Adjuvant bleomycin, etoposide and cisplatin in pathological stage II non-seminomatous testicular cancer. the Indiana University experience. Eur J Cancer (2000) 1.42
Hematologic malignancies associated with primary mediastinal germ-cell tumors. Ann Intern Med (1985) 1.41
Hypoceruloplasminemia-related movement disorder without Kayser-Fleischer rings is different from Wilson disease and not involved in ATP7B mutation. Eur J Neurol (2009) 1.40
Significant activity of paclitaxel in advanced transitional-cell carcinoma of the urothelium: a phase II trial of the Eastern Cooperative Oncology Group. J Clin Oncol (1994) 1.39
Testicular cancer as a model for a curable neoplasm: The Richard and Hinda Rosenthal Foundation Award Lecture. Cancer Res (1981) 1.37
Improved chemotherapy in disseminated testicular cancer. J Urol (1977) 1.37
Long term effect of cis-diamminedichloride platinum (CDDP) on renal function and structure in man. Cancer (1978) 1.35
Phase II study of continuous daily sunitinib dosing in patients with previously treated advanced non-small cell lung cancer. Br J Cancer (2009) 1.33
Spontaneous regression of primary autoreactivity during chronic progression of experimental autoimmune encephalomyelitis and multiple sclerosis. J Exp Med (1999) 1.33
Stat3-coordinated Lin-28-let-7-HMGA2 and miR-200-ZEB1 circuits initiate and maintain oncostatin M-driven epithelial-mesenchymal transition. Oncogene (2013) 1.32
Lupus pregnancy. Case-control prospective study demonstrating absence of lupus exacerbation during or after pregnancy. Am J Med (1984) 1.32
Fertility after chemotherapy for testicular cancer. J Clin Oncol (1983) 1.32
Retinal targets for calmodulin include proteins implicated in synaptic transmission. J Biol Chem (1998) 1.31
How well do questionnaires perform compared with physical examination in detecting flexural eczema? Findings from the International Study of Asthma and Allergies in Childhood (ISAAC) Phase Two. Br J Dermatol (2009) 1.30
Immediate adjuvant chemotherapy versus observation with treatment at relapse in pathological stage II testicular cancer. N Engl J Med (1987) 1.30
Outcome analysis for patients with persistent nonteratomatous germ cell tumor in postchemotherapy retroperitoneal lymph node dissections. J Clin Oncol (1993) 1.29
Dependence of calmodulin localization in the retina on the NINAC unconventional myosin. Science (1993) 1.29
Treatment of experimental autoimmune encephalomyelitis with genetically modified memory T cells. J Exp Med (1997) 1.28
Development of novel cell surface CD34-targeted recombinant adenoassociated virus vectors for gene therapy. Hum Gene Ther (1998) 1.27
Cisplatin, doxorubicin, and cyclophosphamide plus thoracic radiation therapy for limited-stage unresectable thymoma: an intergroup trial. J Clin Oncol (1997) 1.26
AAC-11, a novel cDNA that inhibits apoptosis after growth factor withdrawal. Cancer Res (1997) 1.25
Prognostic correlations and response to treatment in advanced metastatic malignant melanoma. Cancer Res (1974) 1.25
Testicular cancer: the quest continues. J Natl Cancer Inst (1988) 1.25
A novel P/V/C gene in a new member of the Paramyxoviridae family, which causes lethal infection in humans, horses, and other animals. J Virol (1998) 1.25
Early understanding of mental entities: a reexamination of childhood realism. Child Dev (1986) 1.24
Effect of human immunodeficiency virus type 1 protein R (vpr) gene expression on basic cellular function of fission yeast Schizosaccharomyces pombe. J Virol (1996) 1.24
Exercise-induced changes in expression and activity of proteins involved in insulin signal transduction in skeletal muscle: differential effects on insulin-receptor substrates 1 and 2. Proc Natl Acad Sci U S A (2000) 1.24
RIG-E, a human homolog of the murine Ly-6 family, is induced by retinoic acid during the differentiation of acute promyelocytic leukemia cell. Proc Natl Acad Sci U S A (1996) 1.23
Gastrin stimulates the self-replication rate of enterochromaffinlike cells in the rat stomach. Effects of omeprazole, ranitidine, and gastrin-17 in intact and antrectomized rats. Gastroenterology (1990) 1.23
Germ cell tumor associated primitive neuroectodermal tumors. J Urol (2001) 1.23
Randomized study of cisplatin dose intensity in poor-risk germ cell tumors: a Southeastern Cancer Study Group and Southwest Oncology Group protocol. J Clin Oncol (1991) 1.22
Cisplatin as first-line therapy for metastatic breast cancer. J Clin Oncol (1988) 1.22
The role of maintenance therapy in disseminated testicular cancer. N Engl J Med (1981) 1.22
Influenza surveillance in Singapore: 1972-86. Bull World Health Organ (1988) 1.19
Identification of the 16S rRNA m5C967 methyltransferase from Escherichia coli. Biochemistry (1999) 1.19
Late relapse of clinical stage I testicular cancer. J Urol (1995) 1.17
HIV-1 Vpr induces cell cycle G2 arrest in fission yeast (Schizosaccharomyces pombe) through a pathway involving regulatory and catalytic subunits of PP2A and acting on both Wee1 and Cdc25. Virology (2001) 1.17
CD34+ cell dose predicts survival, posttransplant morbidity, and rate of hematologic recovery after allogeneic marrow transplants for hematologic malignancies. Blood (1996) 1.17
Importance of bleomycin in favorable-prognosis disseminated germ cell tumors: an Eastern Cooperative Oncology Group trial. J Clin Oncol (1995) 1.16
Genetic variation and pathogenicity of highly virulent porcine reproductive and respiratory syndrome virus emerging in China. Arch Virol (2009) 1.16
In vivo effects of interferon beta-1a on immunosuppressive cytokines in multiple sclerosis. Neurology (1998) 1.16
Miniature Fabry-Perot pressure sensor created by using UV-molding process with an optical fiber based mold. Opt Express (2012) 1.15
Results of modern therapy for patients with mediastinal nonseminomatous germ cell tumors. Cancer (2000) 1.15